Mouse models of resuscitated shock

Shock

Volumn 24, Issue SUPPL. 1, 2005, Pages 58-63

  Hollenberg, Steven M ^a  

^a Department of Anesthesiology   (United States)

Author keywords

Animal models; Hemodynamics; Knockout mice; Sepsis; Shock

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE;

ECHOCARDIOGRAPHY; HEMODYNAMICS; KNOCKOUT MOUSE; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, TRANSGENIC; RESUSCITATION; SHOCK, SEPTIC;

EID: 33646790885     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000191415.02085.48     Document Type: Review

References (40)

1. Hollenberg SM, Parrillo JE: Shock. In Fauci AS, Braunwald E, Isselbacher KJ, et al. (eds): Harrison's Principles of Internal Medicine, ed 14. New York: McGraw-Hill, 1997, pp 214-222.
2. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, Ognibene FP: Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 113:227-242, 1990.
3. Hollenberg SM, Cunnion RE, Zimmerberg J: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 264:H660-H663, 1993.
4. Evans T, Carpenter A, Kinderman H, Cohen J: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 41:77-81, 1993.
5. Rees DD: Role of nitric oxide in the vascular dysfunction of septic shock. Biochem Soc Trans 23:1025-1029, 1995.
6. Zweifach BW, Fronek A: The interplay of central and peripheral factors in irreversible hemorrhagic shock. Prog Cardiovasc Dis 18:147-180, 1975.
7. Szabo C, Thiemermann C: Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock 2:145-155, 1994.
8. Hochman JS: Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107:2998-3002, 2003.
9. Chernow B, Rainey TR, Lake CR: Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 10:409-416, 1982.
10. Piper RD, Cook DJ, Bone RC, Sibbald WJ: Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med 24:2059-2070, 1996.
11. Cunnion RE, Parrillo JE: Myocardial dysfunction in sepsis. Crit Care Clin 5:99-118, 1989.
12. Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE: Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483-490, 1984.
13. Hollenberg SM, Cunnion RE: Endothelial and vascular smooth muscle function in sepsis. J Crit Care 9:262-280, 1994.
14. Cryer HM, Garrison RN, Harris PD: Role of muscle microvasculature during hyperdynamic and hypodynamic phases of endotoxin shock in decerebrate rats. J Trauma 28:312-318, 1988.
15. Natanson C, Fink MP, Ballantyne HK, MacVittie TJ, Conklin JJ, Parrillo JE: Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest 78:259-270, 1986.
16. Natanson C, Danner RL, Reilly JM, Doerfler ML, Hoffman WD, Akin GL, Hosseini JM, Banks SM, Elin RJ, MacVittie TJ: Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol 259:H1440-H1447, 1990.
17. Carroll G, Snyder J: Hyperdynamic severe intravascular sepsis depends on fluid administration in cynomolgus monkey. Am J Physiol 243:R131-R141, 1982.
18. Meyer J, Traber LD, Nelson S, Lentz CW, Nakazawa H, Heradon DN, Noda H, Taber DL: Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 73:324-328, 1992.
19. Hollenberg SM, Ahrens TS, Task Force of the American College of Critical Care Medicine, et al.: Practice parameters for hemodynamic support of sepsis in adult patients. Crit Care Med 27:639-660, 1999.
20. Fink MP, Heard SO: Laboratory models of sepsis and septic shock. J Surg Res 49:186-196, 1990.
21. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner RL: Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 120:771-783, 1994.
22. Redl H, Bahrami S, Schlag G, Traber DL: Clinical detection of LPS and animal models of endotoxemia. Immunobiology 187:330-345, 1993.
23. Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G: Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4:89-95, 1995.
24. Parker MM, Shelhamer JH, Natanson C, Ailing DW, Parrillo JE: Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. Crit Care Med 15:923-929, 1987.
25. Hollenberg SM, Dumasius A, Easington C, Colilla SA, Neumann A, Parrillo JE: Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med 164:891-895, 2001.
26. Ochoa JB, Udekwu AO, Billiar TR, Curran RD, Cerra FB, Simmons PL, Peitzman AB: Nitrogen oxide levels inpatients after trauma and during sepsis. Ann Surg 214:621-626, 1991.
27. Gomez-Jimenez J, Salgado A, Mourelle M, Martin MC, Segura RM, Peracaula R, Moncada S: L-Arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 23:253-258, 1995.
28. Liu SF, Barnes PJ, Evans TW: Time course and cellular localization of lipopolysaccharide-induced inducible nitric oxide synthase messenger RNA expression in the rat in vivo. Crit Care Med 25:512-518, 1997.
29. Annane D, Sanquer S, Sebille V, Faye A, Djuranovic D, Raphael JC, Gajdos P, Bellissant E: Compartmentalised inducible nitric oxide synthase activity in septic shock. Lancet 355:1143-1148, 2000.
30. Nathan C: Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064, 1992.
31. Gray G, Schott C, Julou-Schaeffer G, Fleming I, Parratt JR, Stoclet J-C: The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br J Pharmacol 103:1218-1244, 1991.
32. Lopez A, Lorente JA, Steingrub J, Bakker J, McLuckie A, Willatts S, Brockway M, Anzveto A, Holzapfel L, Breen D, Silverman MS, Takala J, Donaldson J, Ameson C, Grove G, Grossman S, Grover R: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 32:21-30, 2004.
33. Hollenberg SM, Broussard M, Osman J, Parrillo JE: Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase. Circ Res 86:774-778, 2000.
34. Hollenberg SM, Ross F, Parrillo JE: Discordance between microvascular permeability and leukocyte dynamics in septic iNOS-deficient mice. Crit Care Med 31:A3, 2004.
35. Seely AJ, Christou NV: Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 28:2193-2200, 2000.
36. Godin PJ, Buchman TG: Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med 24:1107-1116, 1996.
37. Manela D, Cruz K, Cohen E, Parrillo JE, Hollenberg SM: Blood pressure variability in a murine model of sepsis. Crit Care Med 29:A43, 2002.
38. Manela D, Cohen E, Cruz K, Hollenberg SM: Blood pressure variability in inducible nitric oxide synthase-deficient septic mice. J Investig Med 50:169A, 2002.
39. Gonzalez C, Fernandez A, Martin C, Moncada S, Estrada C: Nitric oxide from endothelium and smooth muscle modulates responses to sympathetic nerve stimulation: implications for endotoxin shock. Biochem Biophys Res Commun 186:150-156, 1992.
40. Zanzinger J, Czachurski J, Seller H: Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res 75:1073-1077, 1994.